Related references
Note: Only part of the references are listed.Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model
Huan Xu et al.
BIOMATERIALS (2020)
Targeting innate sensing in the tumor microenvironment to improve immunotherapy
Zhida Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Prolonged Local In Vivo Delivery of Stimuli-Responsive Nanogels That Rapidly Release Doxorubicin in Triple-Negative Breast Cancer Cells
Yi Zhang et al.
ADVANCED HEALTHCARE MATERIALS (2020)
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
Ozge Saatci et al.
NATURE COMMUNICATIONS (2020)
Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation
Roberto Ravasio et al.
SCIENCE ADVANCES (2020)
Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker-based immunotherapy
Feihu Wang et al.
SCIENCE ADVANCES (2020)
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Helmut Sies et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
Ye Qin et al.
ONCOGENE (2019)
Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
Helai P. Mohammad et al.
NATURE MEDICINE (2019)
Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
Chanyoung Song et al.
NATURE COMMUNICATIONS (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
A Dual-Bioresponsive Drug-Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade
Huitong Ruan et al.
ADVANCED MATERIALS (2019)
Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery
Jinqiang Wang et al.
ACS NANO (2018)
Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade
Shuangjiang Yu et al.
ADVANCED MATERIALS (2018)
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng et al.
CELL (2018)
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
Lina Liu et al.
MOLECULAR THERAPY (2018)
In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
Chao Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
Aurelie S. Cazet et al.
NATURE COMMUNICATIONS (2018)
Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
Yu Chao et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Stem cell fate in cancer growth, progression and therapy resistance
Nikki K. Lytle et al.
NATURE REVIEWS CANCER (2018)
Controlled drug delivery vehicles for cancer treatment and their performance
Sudipta Senapati et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer
Charles J. Bowerman et al.
NANO LETTERS (2017)
Epigenetics in cancer stem cells
Tan Boon Toh et al.
MOLECULAR CANCER (2017)
Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity
Lihui Wang et al.
CELL DEATH & DISEASE (2017)
Self-assembled RNA-triple-helix hydrogel scaffold for microRNA modulation in the tumour microenvironment
Joao Conde et al.
NATURE MATERIALS (2016)
Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model
Joao Conde et al.
NATURE MATERIALS (2016)
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer
Fara Braso-Maristany et al.
NATURE MEDICINE (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Reversible Regulation of Promoter and Enhancer Histone Landscape by DNA Methylation in Mouse Embryonic Stem Cells
Andrew D. King et al.
CELL REPORTS (2016)
Designing hydrogels for controlled drug delivery
Jianyu Li et al.
NATURE REVIEWS MATERIALS (2016)
Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance
Valery Adorno-Cruz et al.
CANCER RESEARCH (2015)
Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5+ liver cancer initiating cells by suppressing negative regulators of β-catenin signaling
Z-J Lei et al.
ONCOGENE (2015)
Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance
Joao Conde et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The TrkB plus cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model
B. Yin et al.
ONCOGENE (2015)
Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
Zhou J. Deng et al.
ACS NANO (2013)
Epigenomic Analysis of Multilineage Differentiation of Human Embryonic Stem Cells
Wei Xie et al.
CELL (2013)
Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer
Ke-Da Yu et al.
CLINICAL CANCER RESEARCH (2013)
Epigenetic Reprogramming in Cancer
Mario L. Suva et al.
SCIENCE (2013)
Pluripotent Stem Cell Protein Sox2 Confers Sensitivity to LSD1 Inhibition in Cancer Cells
Xiaoming Zhang et al.
CELL REPORTS (2013)
Unravelling cancer stem cell potential
Benjamin Beck et al.
NATURE REVIEWS CANCER (2013)
CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma
Yan Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Strategies for the discovery and development of therapies for metastatic breast cancer
Bedrich L. Eckhardt et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties
Jing Wang et al.
CANCER RESEARCH (2011)
LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells
Antonio Adamo et al.
NATURE CELL BIOLOGY (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Nucleosome-Interacting Proteins Regulated by DNA and Histone Methylation
Till Bartke et al.
CELL (2010)
Epigenetic modifications as therapeutic targets
Theresa K. Kelly et al.
NATURE BIOTECHNOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Iet-7 regulates self renewal and tumorigenicity of breast cancer cells
Fengyan Yu et al.
CELL (2007)
Histone lysine demethylases: emerging roles in development, physiology and disease
Yang Shi
NATURE REVIEWS GENETICS (2007)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
S Zhou et al.
NATURE MEDICINE (2001)
Share Paper
